Peyton Howell

Peyton Howell joined Parexel in May 2018 as Chief Commercial & Strategy Officer and President of Consulting services. In this role sha has led the lauch of Parexel's new patient-focused strategy to drive market leading growth and innovation across Clinical Trials.  

Peyton has more than 25 years of  entreprenuerial leadership experience in the healthcare industry and prior to joining Parexel and held several leadership positions with AmerisourceBergen, a Fortune 20 company, as an executive officer including roles leading a portfolio of pharma services companies and specialty pharmacy services.   She was President, Global Sourcing and Manufacturer Relations, responsible for leadership of $150B in manufacturer sourcing relationships. In this role, she led the creation of a new sourcing entity in Bern, Switzerland to support global manufacturer relations and a joint venture with Walgreens. Peyton also previously served as President, Consulting Services for the company, managing a portfolio of industry-leading pharma services (including acquisitions) focused on market access, reimbursement, patient programs, specialty pharmacy, specialty logistics and product commercialization.

Peyton also was a founder of Lash Group, growing the company from an early innovator of patient access services to nearly 5,000 employees and serving as President for nearly 10 years following its acquisition by AmerisourceBergen.

Peyton holds a Masters’ in Healthcare Administration (MHA) from The Ohio State University and a Bachelor of Arts in Speech Communication from The University of Illinois at Urbana-Champaign. In 2020 she was named a Luminary by the Healthcare Businesswomen’s Association (HBA). Peyton serves on the Board of Directors of Tandem Diabetes Care, Inc., as well as the Cancer Equity Initiative for Family Reach, a national 501(c)(3) organization dedicated to eradicating the financial barriers that accompany a cancer diagnosis.